Daily Hot Plays

[Budots]

$AIMD NASDAQ Ainos is partnering with Taiwan Tanabe Seiyaku, a subsidiary of Mitsubishi Tanabe Pharma, to enhance the production and distribution of VELDONA for Sjögren's syndrome. Here are the key benefits:

1. High-Quality Manufacturing: Taiwan Tanabe's PIC/S GMP-certified facility ensures top-quality production .
2. Market Access: Taiwan Tanabe's established presence in Taiwan will facilitate commercialization.
3. Regulatory Support: Their local expertise may expedite the approval process.
4. Strategic Growth: This partnership aligns with Ainos' out licensing strategy and its mission to address unmet medical needs of Sjogren’s Syndrome

This partnership is set to enhance Ainos' capabilities and support the successful commercialization of VELDONA.

👉 Stay tuned for more updates! Read more here: https://www.accesswire.com/950005/water-tower-research-underscores-ainos-partnership-with-taiwan-tanabe-seiyaku-for-veldona-manufacturing-and-marketing